Senior Director, Biostatistics – Late Phase

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company seeks a Senior Director, Biostatistics – Late Phase to lead strategic statistical thinking and contributions to clinical development plans.

Requirements

• Ph.D. or M.S. in Statistics/Biostatistics
• Minimum 10 years (for Ph.D.) and 14 years (for M.S.) of experience in biotech/pharma industry as a statistician
• Extensive experience in design and conduct of phase 3 oncology trials
• Solid knowledge in ICH and other regulatory requirements related to biostatistical activities and clinical trials
• Excellent verbal and written communication skills
• Good interpersonal and project management skills
• Proficiency in SAS and/or R

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities